COPD Theraupetics
The symptoms of COPD cannot be completely eliminated with treatment and the condition usually worsens over time. However, treatment can control symptoms and can sometimes slow the progression of the disease. Medications that help open the airways, called bronchodilators, are a mainstay of treatment for chronic obstructive pulmonary disease. Bronchodilators help to keep airways open and possibly decrease secretions. Short-acting anticholinergic medication (ipratropium, Atrovent) improves lung function and symptoms. If symptoms are mild and infrequent, short-acting anticholinergic medication may be recommended only when you need it, and Long-acting beta agonists may be recommended if your symptoms are not adequately controlled with other treatments. Glucocorticoids taken in pill form or as an injection are sometimes used for short term treatment but are not generally used long-term because of the risk of side effects. Several such combinations are available including fluticasone proprionate/salmeterol (Advair) and budesonide/formoterol (Symbicort), which are taken twice daily, and fluticasone furoate/vilanterol (Breo), which is taken once daily. People with advanced COPD can have low oxygen levels in the blood. This condition, known as hypoxemia and the oxygen level can be measured with a device placed on the finger or with a blood test (arterial blood gas). Fatal fires have occurred in people attempting to smoke while using oxygen. Unintended weight loss caused by shortness of breath usually occurs in people with more advanced lung disease. Not eating enough can lead to malnutrition, which can make symptoms worse and increase the likelihood of infection. Other treatments for COPD are including Noninvasive ventilatory support (the use of a special mask and breathing machine to improve symptoms), anti-anxiety or anti-depressant medications, or morphine-like medications to reduce shortness of breath.
- Bronchodilators
- Inhaled Steroids
- Supplemental Oxygen
- Protein Therapy
- Novel Therapeutics in COPD
Related Conference of COPD Theraupetics
16th International Conference on Chronic Obstructive Pulmonary Disease
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
COPD Theraupetics Conference Speakers
Recommended Sessions
- Lung Diseases
- Airway and Therapeutic Devices
- Asthma and allergy
- Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
- CO-Morbidities in COPD
- COPD Exacerbations
- COPD Theraupetics
- Diagnostic Evaluation of COPD
- Environmental and Occupational lung Disease
- Epidemology of COPD
- Lung cancer
- Lung Transplantation
- Management of COPD
- Pathogenesis of COPD
- Pediatric Pulmonary,Critical care and Sleep
- Pulmonary diseases-treatment and therapies
- Pulmonary Hypertension
- Self-Management and Prevention of COPD
Related Journals
Are you interested in
- Asthma - Pulmonary Meet 2024 (France)
- Asthma and Allergy - COPD CONGRESS 2024 (UK)
- Asthma and COPD - COPD_2024 (France)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Cardio Pulmonary Disorders - COPD CONGRESS 2024 (UK)
- Chronic bronchitis - COPD CONGRESS 2024 (UK)
- Chronic Bronchitis - Pulmonary Meet 2024 (France)
- Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- Chronic Obstructive Pulmonary Disease - COPD_2024 (France)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- Co-Morbidities of COPD - COPD_2024 (France)
- COPD - Pulmonary Meet 2024 (France)
- COPD and Air Pollution - COPD CONGRESS 2024 (UK)
- COPD and Cardiovascular Diseases - COPD_2024 (France)
- COPD Complications - COPD_2024 (France)
- COPD Exacerbations - COPD_2024 (France)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Pathogenesis - COPD_2024 (France)
- COPD Pathogenesis - COPD CONGRESS 2024 (UK)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD Therapeutics - COPD_2024 (France)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- COPD: Sign and Symptoms - COPD_2024 (France)
- Cystic Fibrosis - Pulmonary Meet 2024 (France)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Depression and Anxiety in COPD - COPD CONGRESS 2024 (UK)
- Depression and anxiety in COPD - COPD_2024 (France)
- Diagnosis and Treatment of COPD - COPD CONGRESS 2024 (UK)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD_2024 (France)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS 2024 (UK)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Emphysema - Pulmonary Meet 2024 (France)
- Emphysema - COPD CONGRESS 2024 (UK)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Epidemiology of COPD - COPD_2024 (France)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Genetic risk factor of COPD - COPD_2024 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2024 (France)
- Interstitial lung disease - Pulmonary Meet 2024 (France)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD_2024 (France)
- Lung Cancer - Pulmonary Meet 2024 (France)
- Lung cancer - COPD CONGRESS 2024 (UK)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS 2024 (UK)
- Lung problems - Pulmonary Meet 2024 (France)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Lung transplantation - Pulmonary Meet 2024 (France)
- Lung Transplantation - COPD CONGRESS 2024 (UK)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pathophysiology of COPD - COPD_2024 (France)
- Pediatric Neonatal Care in COPD - COPD CONGRESS 2024 (UK)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2024 (France)
- Pediatric Pulmonology & Critical care - COPD CONGRESS 2024 (UK)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Pleural Diseases - Pulmonary Meet 2024 (France)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2024 (France)
- Prevention of COPD - COPD CONGRESS 2024 (UK)
- Pulmonary diseases - COPD CONGRESS 2024 (UK)
- Pulmonary diseases-treatment and therapies - COPD_2024 (France)
- Pulmonary Hypertension - COPD_2024 (France)
- Pulmonary Hypertension - Pulmonary Meet 2024 (France)
- Pulmonary Rehabilitation - Pulmonary Meet 2024 (France)
- Pulmonary Rehabilitation - COPD CONGRESS 2024 (UK)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Pulmonary vascular disease - Pulmonary Meet 2024 (France)
- Pulmonology - Pulmonary Meet 2024 (France)
- Respiratory and sleep Medicine - COPD CONGRESS 2024 (UK)
- Respiratory Disorders - Pulmonary Meet 2024 (France)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Failure and COPD Complications: - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - Pulmonary Meet 2024 (France)
- Self-Management and Prevention of COPD - COPD_2024 (France)
- Self-Management and Prevention of COPD - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2024 (France)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Spirometry - COPD CONGRESS 2024 (UK)
- Stages & Severity on Lung Diseases - COPD CONGRESS 2024 (UK)
- Tobacco control - COPD CONGRESS 2024 (UK)
- Tuberculosis - Pulmonary Meet 2024 (France)
- Types of COPD - COPD_2024 (France)
- Types of COPD - COPD CONGRESS 2024 (UK)